The ACCESS study: Zelen randomised controlled trial of a package of care for people presenting to hospital after self-harm
- PMID: 25614531
- DOI: 10.1192/bjp.bp.113.135780
The ACCESS study: Zelen randomised controlled trial of a package of care for people presenting to hospital after self-harm
Abstract
Background: The problem of people presenting to hospitals with self-harm is important because such presentations are common, there is a clear link to suicide and a high premature mortality. However, the best treatment for this population is unclear.
Aims: To see whether a package of measures, that included regular postcards and problem-solving therapy, improved outcomes at 1 year compared with usual care in people who presented to hospital with self-harm (the ACCESS study: trial registration Australian and New Zealand Clinical Trials Registry ACTRN12609000641291).
Method: The design of the study was a Zelen randomised controlled trial. The primary outcome was re-presentation to hospital with self-harm within 12 months of the index episode.
Results: There were no significant differences in the primary outcome and most of the secondary outcomes between the two groups. About half the people offered problem-solving therapy did not receive it, for various reasons.
Conclusions: The package as offered had little effect on the proportion of people re-presenting to hospital with self-harm. The dose of problem-solving therapy may have been too small to have an effect and there was a difficulty engaging participants in active treatment.
Royal College of Psychiatrists.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical